We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
A new world is possible. Let's not go back to what wasn't working anyway.
Add this topic to your myFT Digest for news straight to your inbox
WHO-backed programme has cut its projected deliveries following setbacks
Infection and death rates are the world’s highest and vaccination take-up is low, forcing renewed restrictions
Concern over booster campaign as advisers urge government to prepare for ‘rapid deployment’ of tighter Covid restrictions
Vaccine drive described as ‘fragmented’ with half the people eligible for third dose yet to come forward
Simple steps now could avoid the need for draconian measures later
US regulatory shake-up will mainly effect people who would otherwise have gone without
Asia-Pacific countries ease restrictions on passengers vaccinated against Covid-19
Ministers weigh fresh restrictions as medics juggle flu cases with rise in emergency demand and patient backlog
Results hailed as ‘important’ but duration of protection still unknown
British Medical Association claims UK government is being ‘wilfully negligent’ in refusing to act
Narendra Modi celebrates ‘triumph of Indian science’ months after devastating second wave
People at high risk of catching coronavirus can now receive any of three vaccines authorised by US health agency
Health secretary urges people to get booster jabs to avoid fresh restrictions
Third-quarter revenues from $56,000-per-year treatment were well below analysts’ expectation of $10m
Russian workplaces to shut down from October 30 amid rising case numbers and deaths
Demand comes as daily death toll hits highest level since March and hospitalisations near 1,000
Stable funding for work on less glamorous diseases would make the system fairer and more resilient
Suggestion ex-secretary of state would have benefited from treatment dismissed as ‘highly speculative’
New half-term vaccine push for teens comes as ministers question progress of third-jab programme
Boston-based EQRx wants to sell medicines at prices 50-70 per cent below rivals
Okonjo-Iweala addressed shipping issues, global trade and Covid vaccine access at FT Africa Summit
Scientist say AY.4.2 seems to be 10%-15% more transmissible but cannot be blamed for high UK Covid-19 case numbers
Trial results come month after UK terminated contract with French company
Bullish projections show mRNA jab producers could generate more than $90bn in sales next year
Head of Royal College of Pathologists says NHS backlog cannot be cleared without more investment in his field
International Edition
